ARCHIVES

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Armitage Appointed to NCAB; UT Board Approves New Clinical Building for MDACC

May 19, 2000

DCBD Board Approved Concepts For New Grants In Cytogenetics Solid Tumor Diagnoses

December 13, 1984

NCAB Can’t Decide Fate of Women’s Health Trial, Forces It Back Into Lap of DCPC Scientific Advisors

October 2, 1987

Cancer Education: NCI Offers Training In Epidemiology And Genetics

April 17, 1998

Cancer Act Doesn’t Require Geographic Distribution Of Comp Centers

March 4, 1977

In Brief: Jennifer Pietenpol Named to IOM Cancer Policy Board

July 18, 2014